Carcinoid tumor and Upper respiratory tract infection

Summary:

Upper respiratory tract infection is found among people with Carcinoid tumor, especially for people who are female, 60+ old.

The study analyzes which people have Upper respiratory tract infection with Carcinoid tumor. It is created by eHealthMe based on reports of 60 people who have Carcinoid tumor from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Feb, 07, 2023

60 people who have Carcinoid Tumor and Upper Respiratory Tract Infection are studied.


What is Carcinoid tumor?

Carcinoid tumor is found to be associated with 391 drugs and 179 conditions by eHealthMe.

What is Upper respiratory tract infection?

Upper respiratory tract infection is found to be associated with 2,507 drugs and 1,587 conditions by eHealthMe.

Number of Upper respiratory tract infection in Carcinoid tumor reports submitted per year:

Would you have Upper respiratory tract infection when you have Carcinoid tumor?

Gender of people who have Carcinoid Tumor and experienced Upper Respiratory Tract Infection *:

  • female: 85.96 %
  • male: 14.04 %

Age of people who have Carcinoid Tumor and experienced Upper Respiratory Tract Infection *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 7.41 %
  • 50-59: 18.52 %
  • 60+: 74.07 %

Common co-existing conditions for these people *:

  1. Medullary Thyroid Cancer (type of thyroid cancer that develops in the parafollicular cells of the thyroid gland): 8 people, 13.33%
  2. Blood Potassium Decreased: 6 people, 10.00%
  3. Stress And Anxiety: 4 people, 6.67%
  4. High Blood Pressure: 4 people, 6.67%
  5. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 5.00%
  6. Arrhythmias (irregular heartbeat): 3 people, 5.00%
  7. Iron Overload: 2 people, 3.33%
  8. Procedural Pain: 1 person, 1.67%
  9. Metastases To Liver (cancer spreads to liver): 1 person, 1.67%
  10. Diarrhea: 1 person, 1.67%

Common drugs taken by these people *:

  1. Sandostatin: 41 people, 68.33%
  2. Amlodipine: 12 people, 20.00%
  3. Celebrex: 8 people, 13.33%
  4. Synthroid: 8 people, 13.33%
  5. Rocaltrol: 8 people, 13.33%
  6. Calcium: 8 people, 13.33%
  7. Caprelsa: 8 people, 13.33%
  8. Dilaudid: 5 people, 8.33%
  9. Cabometyx: 3 people, 5.00%
  10. Altace: 3 people, 5.00%

Common symptoms for these people *:

  1. Cough: 47 people, 78.33%
  2. Diarrhea: 44 people, 73.33%
  3. High Blood Pressure: 42 people, 70.00%
  4. Injection Site Pain: 40 people, 66.67%
  5. Fatigue (feeling of tiredness): 39 people, 65.00%
  6. Nausea (feeling of having an urge to vomit): 36 people, 60.00%
  7. Urinary Tract Infection: 34 people, 56.67%
  8. Dizziness: 32 people, 53.33%
  9. Fall: 26 people, 43.33%
  10. Feeling Abnormal: 26 people, 43.33%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Upper respiratory tract infection?

Check whether Upper respiratory tract infection is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Upper respiratory tract infection:

Common drugs associated with Upper respiratory tract infection:

All the drugs that are associated with Upper respiratory tract infection:

Common conditions associated with Upper respiratory tract infection:

All the conditions that are associated with Upper respiratory tract infection:

How the study uses the data?

The study is based on Upper respiratory tract infection and Carcinoid tumor, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: